Specialized Health Services Stocks' Research Reports Released on Acadia Healthcare, DaVita, MEDNAX, and Tivity Health

Wednesday, March 28, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, March 28, 2018 /PRNewswire/ --

WallStEquities.com strives to bring the best free research to the investment

community.  Today we are offering reports on ACHC, DVA, MD, and TVTY which can be accessed for free by signing up to www.wallstequities.com/registration. On Tuesday, the NASDAQ Composite ended the day at 7,008.81, down 2.93%; the Dow Jones Industrial
Average edged 1.43% lower, to finish at 23,857.71; and the S&P 500 closed at 2,612.62, marginally slipping 1.73%. Losses were broad based as eight out of nine sectors finished the trading session in red. WallStEquities.com has initiated research reports on the following Specialized Health Services stocks: Acadia Healthcare Co. Inc. (NASDAQ: ACHC), DaVita Inc. (NYSE: DVA), MEDNAX Inc. (NYSE: MD), and Tivity Health Inc. (NASDAQ: TVTY). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

Acadia Healthcare

Franklin, Tennessee headquartered Acadia Healthcare Co. Inc.'s stock finished Tuesday's session 0.84% lower at $39.07 with a total trading volume of 967,021 shares. The stock has gained 21.15% over the past three months. The Company's shares are trading above their 50-day moving average by 5.44%. Moreover, shares of Acadia Healthcare, which develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities, have a Relative Strength Index (RSI) of 47.68. Get the full research report on ACHC for free by clicking below at: www.wallstequities.com/registration/?symbol=ACHC

DaVita

Shares in Denver, Colorado headquartered DaVita Inc. declined 0.46%, ending yesterday's session at $65.34 with a total trading volume of 1.15 million shares. The Company's shares are trading above their 200-day moving average by 0.58%. Moreover, shares of DaVita, which provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease, have an RSI of 24.80. Gain free access to the research report on DVA at: www.wallstequities.com/registration/?symbol=DVA

MEDNAX

On Tuesday, Sunrise, Florida-based MEDNAX Inc.'s stock saw a decline of 0.56%, to close the day at $54.75. A total volume of 425,349 shares was traded. The Company's shares have advanced 2.30% in the previous three months. The stock is trading above its 200-day moving average by 8.66%. Additionally, shares of MEDNAX, which together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology, pediatric cardiology, and other pediatric subspecialties physician services in the US and Puerto Rico, have an RSI of 42.56.

On March 27th, 2018, research firm Credit Suisse initiated a 'Neutral' rating on the Company's stock, with a target price of $57 per share. Register for your free report coverage on MD at: www.wallstequities.com/registration/?symbol=MD

Tivity Health

Shares in Franklin, Tennessee headquartered Tivity Health Inc. ended the day flat at $40.00. A total volume of 671,690 shares was traded, which was above their three months average volume of 457.30 thousand shares. The stock has gained 40.35% over the last twelve months. The Company's shares are trading above their 50-day and 200-day moving averages by 2.29% and 3.96%, respectively. Furthermore, shares of Tivity Health, which together with its subsidiaries, provides network delivered solutions and population health management services to help people to enhance well-being and health, have an RSI of 49.05. Get the free research report on TVTY at: www.wallstequities.com/registration/?symbol=TVTY

--

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

WSE has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com Phone number: +21-32-044-483Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

 

Cision View original content:http://www.prnewswire.com/news-releases/specialized-health-services-stocks-research-reports-released-on-acadia-healthcare-davita-mednax-and-tivity-health-300620862.html

SOURCE Wall St. Equities



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store